Core Viewpoint - A securities fraud lawsuit has been filed against Klarna Group plc and certain executives, alleging misleading statements in their IPO registration [1][2]. Group 1: Lawsuit Details - Klarna Group conducted its IPO at $40 per share on September 10, 2025 [2]. - The complaint claims that the Registration Statement contained false and misleading statements, particularly regarding the risk of loss reserves increasing shortly after the IPO [2]. - It is alleged that the defendants either knew or should have known about the risk profile of individuals taking Klarna's buy now, pay later loans, leading to materially false public statements [2]. Group 2: Investor Eligibility - Any investor who purchased Klarna Group plc common stock and experienced a decline in share value may be eligible to participate in the lawsuit, regardless of whether they sold their investment [3]. Group 3: Next Steps for Investors - The deadline to seek appointment as lead plaintiff is March 6, 2026, and a class has not yet been certified [4]. - Investors can choose to remain absent class members if they take no action, but are encouraged to contact Block & Leviton for more information [4]. Group 4: Whistleblower Information - Individuals with non-public information about Klarna Group are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [5]. Group 5: About Block & Leviton - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [6].

Core Viewpoint - A class action lawsuit has been filed against Fiserv, Inc. for allegedly violating federal securities laws by issuing false and misleading statements regarding its business and financial health, leading to a significant decline in stock price and market value [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Fiserv's management, including the CEO and CFO, overstated growth potential and provided unrealistic financial guidance between July 23 and October 28, 2025 [2]. - Following a drastic cut in forecasts and poor third-quarter results, Fiserv's stock price dropped by 44%, resulting in an approximate loss of $30 billion in market value [2]. - Investors were reportedly misled by positive statements about the company's strategic direction, which later proved to be unattainable, necessitating a major overhaul in leadership and business strategy [2]. Group 2: Legal Proceedings - The lawsuit is filed in the Eastern District of Wisconsin under the case name Lombard v. Fiserv, Inc., et al., and is on behalf of all investors who purchased Fiserv stock during the specified class period [3]. - Investors who acquired Fiserv stock during the class period may seek to be appointed as lead plaintiffs, with a deadline for such motions set for January 5, 2026 [4]. - Participation as a lead plaintiff is not required to share in any potential recovery from the lawsuit [5].

Core Insights - Block & Leviton LLP is investigating Barnes & Noble Education, Inc. for potential securities law violations following a significant drop in stock price due to accounting errors [1][2][5] Financial Reporting Issues - On July 21, 2025, Barnes & Noble's stock price fell over 20% after the company disclosed delays in filing its annual report, attributed to accounting errors [2] - An internal investigation indicated that the company may have overstated accounts receivable by up to $23 million, raising concerns about the accuracy of its financial reporting [2] - The company expects to identify at least one material weakness in internal controls, suggesting ineffective disclosure procedures for multiple fiscal years [2] Regulatory Filings - On September 12, 2025, Barnes & Noble announced a delay in filing its Form 10-Q for the period ending August 2, 2025, primarily due to the ongoing internal investigation [3] Investor Eligibility - Any investor who purchased Barnes & Noble Education, Inc. common stock and experienced a decline in share value may be eligible to seek recovery of losses [4] Legal Actions - Block & Leviton is actively investigating whether Barnes & Noble committed securities law violations and may file actions to recover losses for affected investors [5] Whistleblower Information - Individuals with non-public information about Barnes & Noble are encouraged to assist in the investigation or report to the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [7]

Core Viewpoint - A class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly violating federal securities laws by making false and misleading statements regarding the company's business and operations [1][2]. Group 1: Allegations of Misleading Statements - The lawsuit claims that Hims & Hers made false statements about a collaboration with Novo Nordisk that would ensure continued access to the weight-loss drug Wegovy for its subscribers [2]. - It is alleged that Hims & Hers misrepresented that Novo approved its offerings of compounded semaglutide products under a "personalization" exception [2]. - The suit contends that Hims & Hers falsely indicated that branded Wegovy would be available alongside compounded semaglutide options, thereby misleading investors about user choice [2]. - Positive statements regarding the partnership with Novo and ongoing access to Wegovy were also allegedly made, which contributed to the decline in the company's stock value [2]. Group 2: Legal Proceedings - The lawsuit was filed in the Northern District of California and is captioned Yaghsizian v. Hims & Hers Health, Inc., et al., No. 3:25-cv-05321 (N.D. Cal.) [3]. - The class action is on behalf of all individuals who purchased Hims & Hers common stock between April 29, 2025, and June 23, 2025 [3]. Group 3: Class Member Information - Investors who acquired Hims & Hers stock during the specified class period may seek to be appointed as lead plaintiffs, with a deadline to do so by August 25, 2025 [4]. - It is noted that investors do not need to be lead plaintiffs to participate in any potential recovery from the lawsuit [5].

Group 1 - The Portnoy Law Firm has initiated an investigation into D-Wave Quantum Inc. for possible securities fraud and may file a class action on behalf of investors [1][3] - Block & Leviton LLP is also investigating D-Wave Quantum Inc. following a report by Kerrisdale Capital, which questions the credibility of D-Wave's technology and claims it is more of a marketing strategy than a genuine advancement in quantum computing [3] - D-Wave Quantum's stock experienced a decline of up to 6% during intraday trading after the release of the Kerrisdale Capital report [3] Group 2 - The Portnoy Law Firm offers a complimentary case evaluation for investors seeking to recover losses and encourages them to contact attorney Lesley F. Portnoy [2][4] - The founding partner of the Portnoy Law Firm has successfully recovered over $5.5 billion for aggrieved investors [4]

Core Viewpoint - A class action lawsuit has been filed against Fluence Energy, Inc. for allegedly violating federal securities laws by making false and misleading statements about its business and operations [1][2]. Group 1: Allegations - The lawsuit claims that Fluence Energy made false and misleading statements and failed to disclose material facts, including the potential decline of its relationships with major revenue sources, Siemens AG and The AES Corporation [2]. - It is alleged that Siemens Energy accused Fluence of engineering failures and fraud, which could impact the company's credibility [2]. - The lawsuit asserts that Fluence's reported margins and revenue growth were inflated due to the impending divestment by Siemens and AES [2]. - The defendants are said to have lacked a reasonable basis for their positive statements regarding Fluence's battery energy storage business and its financial prospects [2]. Group 2: Legal Proceedings - The lawsuit was filed in the Eastern District of Virginia under the case caption Daniel Abramov v. Fluence Energy, Inc., et al., and covers the period from November 29, 2023, to February 10, 2025 [3]. - Investors who purchased Fluence Energy stock during the class period may seek to be appointed as lead plaintiffs, with a deadline for such motions set for May 12, 2025 [4]. Group 3: Investor Information - Investors do not need to be lead plaintiffs to participate in any potential recovery and can choose their own legal representation [5].